{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:33:24Z","timestamp":1785202404806,"version":"3.55.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"Background<\/jats:title>Antimicrobial resistance (AMR) can lead to fatal consequences. AMR genes carriage by phenotypically susceptible bacteria, such as Extended-Spectrum \u03b2-Lactamases (ESBL)s in Enterobacteriaceae<\/jats:italic>, have potential implications for AMR spread and therapeutic outcomes. This phenomenon should be investigated.<\/jats:p><\/jats:sec>Methods<\/jats:title>Positive blood cultures from hospitalized patients in a Malaysian tertiary center between April 2022 and March 2023 were reviewed. A total of 137 clinical isolates of Escherichia coli (E.coli<\/jats:italic>), Klebsiella pneumoniae<\/jats:italic> (K.pneumoniae<\/jats:italic>), and Klebsiella oxytoca<\/jats:italic> were included. The antibiotic susceptibility and ESBL phenotypes were determined by disk diffusion method and the identification of genotypes by multiplex polymerase chain reaction. The clinical characteristics and outcome information were extracted by reviewing patients\u2019 medical records to evaluate the clinical significance of the ESBL genotype-positive but phenotype-negative isolates in bacteremia.<\/jats:p><\/jats:sec>Results<\/jats:title>All 137 isolates were positive for at least one genotype (bla<\/jats:italic>CTX-M<\/jats:sub>, n = 71, 51.8%; bla<\/jats:italic>SHV<\/jats:sub>, n = 87, 63.5%; bla<\/jats:italic>TEM<\/jats:sub>, n = 95, 69.3%; bla<\/jats:italic>OXA-1<\/jats:sub>, n = 38, 27.7%). While bla<\/jats:italic>CTX-M<\/jats:sub> was proportionately higher in the ESBL phenotype-positive isolates than ESBL phenotype-negative isolates (33\/37, 89.2% vs 38\/100, 38%; p &lt; 0.001), more than half of those harboring bla<\/jats:italic>CTX-M<\/jats:sub> remained susceptible to third-generation cephalosporins (3GC). The sensitivity (Sen) of bla<\/jats:italic>CTX-M<\/jats:sub> for ESBL phenotypes prediction was 89.19% (95% confidence interval [CI], 74.58 - 96.97%); however, specificity (Sp) was low (46.47%; 95% CI 39.75 - 53.32). The patient characteristics were similar among 98 ESBL phenotype-negative cases, except that the non-bla<\/jats:italic>CTX-M<\/jats:sub> carrier group had significantly more renal impairment (0\/37 vs 7\/61, p = 0.043) and gastrointestinal sources of bacteremia (9\/37 vs 27\/61, p = 0.047). No differences were observed in infection severity, in-hospital mortality, and length of stay (LOS) between the bla<\/jats:italic>CTX-M<\/jats:sub> and non-bla<\/jats:italic>CTX-M<\/jats:sub> carrier groups.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The current study provides insight into the gene carriage in E.coli<\/jats:italic> and Klebsiella species<\/jats:italic> clinical isolates, including bla<\/jats:italic>CTX-M<\/jats:sub> genotypes in antibiotic-susceptible strains from a Malaysian hospital. The ESBL encoding genotypes such as bla<\/jats:italic>CTX-M<\/jats:sub> presented substantially beyond one-third of the ESBL phenotype-negative or 3GC susceptible E.coli<\/jats:italic> and K.pneumoniae<\/jats:italic> isolated from bloodstream infection. Although clinical outcomes were not worsened with bla<\/jats:italic>CTX-M<\/jats:sub> genotype-positive but ESBL phenotype-negative isolates in bacteremia, the potential implications for AMR spread deserve further investigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1429830","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:10:24Z","timestamp":1729746624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative Escherichia coli and Klebsiella pneumoniae clinical isolates in bacteremia: a study in a Malaysian tertiary center"],"prefix":"10.3389","volume":"14","author":[{"given":"Chee Lan","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-min","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrick","family":"Periyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tg Mohd Ikhwan","family":"Tg Abu Bakar Sidik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toh Leong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramliza","family":"Ramli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Naina Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43094-022-00406-8","article-title":"Mortality and its predictors among hospitalized patients with infections due to extended spectrum beta-lactamase (ESBL) Enterobacteriaceae in Malaysia: a retrospective observational study","volume":"8","author":"Abubakar","year":"2022","journal-title":"Future J. Pharm. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/antibiotics9070418","article-title":"Narrow-spectrum antibacterial agents\u2014Benefits and challenges","volume":"9","author":"Alm","year":"2020","journal-title":"Antibiotics"},{"key":"B3","first-page":"440","article-title":"The risk factors for complications and survival outcomes of Klebsiella pneumoniae Bacteraemia in Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia","volume":"77","author":"Ang","year":"2022","journal-title":"Med. J. Malaysia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/jac\/dkx146","article-title":"Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype","volume":"72","author":"Bevan","year":"2017","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.amjms.2018.11.009","article-title":"Impact of delayed appropriate antibiotic therapy on patient outcomes by antibiotic resistance status from serious gram negative bacterial infections","volume":"357","author":"Bonine","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijantimicag.2017.12.013","article-title":"Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis","volume":"51","author":"Carrara","year":"2018","journal-title":"Int. J. Antimicrobial Agents"},{"key":"B7","unstructured":"Guidelines for Environmental Infection Control in Health-Care Facilities\n \n 2003"},{"key":"B8","unstructured":"Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection)\n \n 2022"},{"key":"B9","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100","year":"2022"},{"key":"B10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. reviews: MMBR"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.3390\/ijms21145090","article-title":"Molecular mechanisms, epidemiology, and clinical importance of \u03b2-lactam resistance in enterobacteriaceae","volume":"21","author":"De Angelis","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cmi.2019.11.009","article-title":"Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis","volume":"26","author":"De Angelis","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1111\/jam.15738","article-title":"[amp]]lsquo;To be, or not to be\u2019\u2014The dilemma of \u2018silent\u2019 antimicrobial resistance genes in bacteria","volume":"133","author":"Deekshit","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1093\/jac\/dkaa161","article-title":"Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it","volume":"75","author":"de Lastours","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijid.2020.09.078","article-title":"High rate of multidrug-resistant Enterobacteriaceae carrying ESBL and plasmid-borne AmpC \u00df-lactamase in a Malaysian community","volume":"101","author":"Dwiyanto","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/23744235.2023.2261538","article-title":"Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli","volume":"56","author":"Handal","year":"2024","journal-title":"Infect. Dis. (Lond)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/cid\/ciad703","article-title":"Is carbapenem therapy necessary for the treatment of non-CTX-M extended-spectrum \u03b2-lactamase-producing enterobacterales bloodstream infections","volume":"78","author":"Hareza","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.17576\/MH.2022.1702.05","article-title":"Risk factors for severe outcomes in extended-spectrum beta-lactamase (ESBL) bacteremia: A single-center study","volume":"17","author":"Hazwan","year":"2022","journal-title":"Med. Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e3842","DOI":"10.1093\/cid\/ciaa1479","article-title":"Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin\/tazobactam or meropenem from the MERINO study","volume":"73","author":"Henderson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12785","DOI":"10.1038\/s41598-018-31081-6","article-title":"No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia","volume":"8","author":"Heng","year":"2018","journal-title":"Sci. Rep."},{"key":"B21","volume-title":"Institute of Medical Research. National Surveillance of Antimicrobial Resistance, Malaysia.","year":"2023"},{"key":"B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrobial Resistance Infection Control"},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","article-title":"Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic Malignancy","volume":"91","author":"Kang","year":"2012","journal-title":"Ann. Hematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.1128\/AAC.01477-15","article-title":"Cefepime therapy for monomicrobial enterobacter cloacae bacteremia: unfavorable outcomes in patients infected by cefepime-susceptible dose-dependent isolates","volume":"59","author":"Lee","year":"2015","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020131","article-title":"Molecular epidemiology of extended-spectrum beta-lactamase and ampC producing enterobacteriaceae among sepsis patients in Ethiopia: A prospective multicenter study","volume":"11","author":"Legese","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/165637","article-title":"Characterization of multidrug resistant ESBL-producing escherichia coli isolates from hospitals in Malaysia","volume":"2009","author":"Lim","year":"2009","journal-title":"J. Biomedicine Biotechnol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1099\/jmm.0.011114-0","article-title":"Characterization of multidrug-resistant and extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals","volume":"58","author":"Lim","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab068","article-title":"Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis","volume":"3","author":"Ling","year":"2021","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/inf.0000000000002916","article-title":"A multicentered study of the clinical and molecular epidemiology of TEM- and SHV-type extended-spectrum beta-lactamase producing enterobacterales infections in children","volume":"40","author":"Logan","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2147\/idr.S442646","article-title":"CTX-M, TEM, and SHV Genes in Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp Isolated from Hematologic Cancer Patients with Bacteremia in Uganda","volume":"17","author":"Lubwama","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab020","article-title":"CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales","volume":"3","author":"Mathers","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"B32","unstructured":"Diagnostic test evaluation calculator (Version 22.023)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01485-21","article-title":"Correlation between identification of \u03b2-lactamase resistance genes and antimicrobial susceptibility profiles in gram-negative bacteria: a laboratory data analysis","volume":"10","author":"Mushtaq","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-021-00936-5","article-title":"Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia","volume":"10","author":"Ngoi","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091140","article-title":"Detection of multidrug-resistant Enterobacterales\u2014from ESBLs to carbapenemases","volume":"10","author":"Noster","year":"2021","journal-title":"Antibiotics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ja.2015.68","article-title":"Development of a multiplex PCR system and its application in detection of blaSHV, blaTEM, blaCTX-M-1, blaCTX-M-9 and blaOXA-1 group genes in clinical Klebsiella pneumoniae and Escherichia coli strains","volume":"68","author":"Ogutu","year":"2015","journal-title":"J. Antibiot (Tokyo)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3329\/bjms.v15i2.27849","article-title":"Detection of CTX-M-type ESBLs Escherichia coli at Universiti Kebangsaan Malaysia Medical Centre","volume":"15","author":"Othman","year":"2016","journal-title":"Bangladesh J. Med. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/cmr.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008%m14706969","article-title":"International prospective study of klebsiella pneumoniae bacteremia: implications of extended-spectrum \u03b2-lactamase production in nosocomial infections","volume":"140","author":"Paterson","year":"2004","journal-title":"Ann. Internal Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1038\/s41598-019-39730-0","article-title":"Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli","volume":"9","author":"Ramadan","year":"2019","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13756-023-01346-5","article-title":"Epidemiology of multidrug-resistant Klebsiella pneumoniae infection in clinical setting in South-Eastern Asia: a systematic review and meta-analysis","volume":"12","author":"Salawudeen","year":"2023","journal-title":"Antimicrobial Resistance Infection Control"},{"key":"B43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3923\/JM.2008.489.493","article-title":"Extended-spectrum \u03b2-lactamases-producing Escherichia coli from a tertiary hospital in Malaysia: emergence of CTX-M-type \u03b2-lactamases variation","volume":"3","author":"Sekawi","year":"2008","journal-title":"Res. J. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030266","article-title":"Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"10","author":"Shamsrizi","year":"2020","journal-title":"BMJ Open"},{"key":"B45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"B46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12941-021-00466-3","article-title":"Molecular detection of bla(CTX-M) gene to predict phenotypic cephalosporin resistance and clinical outcome of Escherichia coli bloodstream infections in Vietnam","volume":"20","author":"Son","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.33073\/pjm-2021-040","article-title":"Silent genes: antimicrobial resistance and antibiotic production","volume":"70","author":"Stasiak","year":"2021","journal-title":"Pol. J. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","article-title":"Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum \u03b2-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab019","article-title":"PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress","volume":"3","author":"Tamma","year":"2021","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JCM.00127-21","article-title":"Prevalence of blaCTX-M Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States","volume":"59","author":"Tamma","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jgar.2020.08.011","article-title":"Does the presence of multiple \u03b2-lactamases in Gram-negative bacilli impact the results of antimicrobial susceptibility tests and extended-spectrum \u03b2-lactamase and carbapenemase confirmation methods","volume":"23","author":"Tenover","year":"2020","journal-title":"J. Global Antimicrobial Resistance"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1097\/ccm.0000000000000516","article-title":"Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock","volume":"42","author":"Vazquez-Guillamet","year":"2014","journal-title":"Crit. Care Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"dlab035","DOI":"10.1093\/jacamr\/dlab035","article-title":"Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO\/CON debate","volume":"3","author":"Villegas","year":"2021","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10096-015-2350-9","article-title":"Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia","volume":"34","author":"Vlieghe","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.07.006","article-title":"Towards a phenotypic screening strategy for emerging-lactamases in Gram-negative bacilli","volume":"41","author":"Willems","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B57","unstructured":"World Health Organization. Global Action Plan on Antimicrobial Resistance\n \n 2016"},{"key":"B58","unstructured":"Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis\n \n 2017"},{"key":"B59","unstructured":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022\n \n 2022"},{"key":"B60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10096-010-1048-2","article-title":"Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases","volume":"30","author":"Wu","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16393","article-title":"A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia","volume":"11","author":"Yap","year":"2023","journal-title":"PeerJ"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e00138","DOI":"10.1128\/JCM.00138-20","article-title":"The genotype-to-phenotype dilemma: how should laboratories approach discordant susceptibility results","volume":"59","author":"Yee","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jgar.2023.11.013","article-title":"Epidemiology and molecular characterization of CTX-M-type ESBLs producing Escherichia coli isolated from clinical settings","volume":"36","author":"Yu","year":"2024","journal-title":"J. Global Antimicrobial Resistance"},{"key":"B64","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/mdr.2017.0018","article-title":"Characterization of unexpressed extended-spectrum beta-lactamase genes in antibiotic-sensitive klebsiella pneumoniae isolates","volume":"24","author":"Zhang","year":"2018","journal-title":"Microb. Drug Resist."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1429830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:10:30Z","timestamp":1729746630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1429830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":64,"alternative-id":["10.3389\/fcimb.2024.1429830"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1429830","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"article-number":"1429830"}}